PRINCETON, N.J., Dec. 10, 2003 (PRIMEZONE) -- FindProfit (www.findprofit.com), an investment service that delivered a +73% audited return in 2002, announced today that it has provided to trial and paid subscribers "Biotech Sector Outlook," the eighth special report in the FindProfit Expert Insight Series. Among the companies covered in the report are Millennium Pharmaceuticals (NASDAQ:MLNM) and Genetech (NYSE:DNA).
FindProfit's previous Expert Insight Series report, "Global Investing Outlook," looked at investment opportunities in Asia. "Biotech Sector Outlook" focuses on the biotech sector at-large and a number of companies, including CV Therapeutics (NASDAQ:CVTX) and Amgen (NASDAQ:AMGN).
All paid and trial FindProfit subscribers can now receive immediate access to FindProfit's exclusive reports and ongoing commentary and analysis. As a trial or paid subscriber, you'll also gain access to our latest investment moves. Start your 30-day free trial today: http://www.findprofit.com/subscribe.php3?refer=zone58
FindProfit's "Biotech Sector Outlook" examines the following questions:
-- How stretched are valuations for most individual biotech stocks
at this point?
-- Where are the opportunities? And what areas should investors
avoid?
-- What is the outlook for the biotech sector in 2004 and what will
be the key themes that emerge in this area?
-- How should an individual investor that doesn't have a science
background go about researching potential biotech opportunities?
And what are some guidelines they can follow to help increase
their chances of investment success and stay away from the hype?
-- Are there opportunities in the big pharmaceutical stocks?
-- With the market for biotech IPOs strong and more private equity
flowing into the sector, is a short-term peak for the sector on
the horizon?
And More
Sign up now for a 30-day free trial to FindProfit and you'll gain instant access to FindProfit's in depth coverage of the restaurant and retail sector, as well as our full "as it happens" investment commentary and comprehensive model portfolios, by clicking here: http://www.findprofit.com/subscribe.php3?refer=zone58
Subscribers also receive access to FindProfit's Special Bonus Report, "Five MUST-OWN Bargain Stocks!"
Subscribers are always protected by FindProfit's 100% customer satisfaction guarantee.
FindProfit finds you winners. The service posted a +73% audited-return in 2002, and model portfolio gains of 157%, 104% and 37% since August 2002.
About FindProfit.com:
FindProfit.com is a leading publisher and provider of lively, fun, and profitable investment commentary for individual investors who love the stock market. As a 100% independent investment service, FindProfit's only bias is towards making its subscribers money. FindProfit's real-time "as it happens" investment service gives individual investors the edge they need to consistently beat the market. For more information or to sign up now for a free 30-day trial to FindProfit, please visit: http://www.findprofit.com/subscribe.php3?refer=zone58
NOTE: FindProfit, LLC is not a registered broker dealer, registered investment adviser or registered research analyst.